Sign in

CIK 0001740279

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

IN8BIO, INC.

Sign in to watch
Ticker
INAB
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
825462585
Phone
+1 646-600-6438
Business address
EMPIRE STATE BUILDING, 350 5TH AVENUE, SUITE 5330, NEW YORK, NY, 10118
Former names
Incysus Therapeutics, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2022-06-01 Whitfill Travis Director Grant or award · Stock Option (right to buy) +13,500 13,500
2022-06-01 Roemer Alan S. Director Grant or award · Stock Option (right to buy) +13,500 13,500
2022-06-01 Greenwood Luba Director Grant or award · Stock Option (right to buy) +13,500 13,500
2022-06-01 FAIRBAIRN EMILY Director Grant or award · Stock Option (right to buy) +13,500 13,500
2022-06-01 Brandt Peter C. Director Grant or award · Stock Option (right to buy) +13,500 13,500
2022-06-01 Brandt Peter C. Director Grant or award · Stock Option (right to buy) +10,500 10,500
2022-06-01 FAIRBAIRN EMILY Director Grant or award · Stock Option (right to buy) +10,500 10,500
2022-06-01 Greenwood Luba Director Grant or award · Stock Option (right to buy) +10,500 10,500
2022-06-01 Roemer Alan S. Director Grant or award · Stock Option (right to buy) +10,500 10,500
2022-06-01 Whitfill Travis Director Grant or award · Stock Option (right to buy) +10,500 10,500
2022-05-05 Lamb Lawrence EVP and CSO Exercise or conversion +26,204 $1.07 $28K 99,204
2022-05-05 Lamb Lawrence EVP and CSO Exercise or conversion · Employee Stock Option (right to buy) −26,204 1,171
2022-02-15 McCall Patrick Chief Financial Officer Grant or award · Employee Stock Option (right to buy) +84,500 84,500
2022-02-15 Goswami Trishna Chief Medical Officer Grant or award · Employee Stock Option (right to buy) +90,500 90,500
2022-02-15 Lamb Lawrence EVP and CSO Grant or award · Employee Stock Option (right to buy) +62,500 62,500
2022-02-15 Rochlin Kate Chief Operating Officer Grant or award · Employee Stock Option (right to buy) +96,000 96,000
2022-02-15 Ho William Tai-Wei President, CEO and CFO Grant or award · Employee Stock Option (right to buy) +254,500 254,500
2021-11-19 Roemer Alan S. Director Grant or award · Stock Option (right to buy) +86,258 86,258
2021-11-19 Goswami Trishna Chief Medical Officer Grant or award · Employee Stock Option (right to buy) +250,000 250,000
2021-08-13 Kreis Leslie W. 10% owner Other acquisition · Stock Option (right to buy) +12,775 12,775

Page 13 of 16 · 309 trades